Market News

Next stop: Ad break? DMRC plans in-train audio ads on 4 metro lines

Delhi Metro is set to introduce in-train audio advertisements on its Red, Yellow, Blue, and Magenta lines to boost revenue. This move aims to transform trains into a premium advertising platform, mirroring global transit systems. Advertisements will be aired only during silent intervals between essential passenger announcements, ensuring information flow remains uninterrupted.

Maersk places order for 1,000 shipping containers with DCM Shriram Group

Global shipping giant AP Moller-Maersk has ordered 1,000 more India-made shipping containers from DCM Shriram Group. Union Minister Sarbananda Sonowal unveiled the first such container, marking a significant step towards self-reliance in maritime manufacturing. This partnership is set to boost India's global supply chain presence and manufacturing capabilities, supported by government initiatives promoting domestic production.

Gold prices to stay elevated, volatile; Titan bullish on long-term growth

Gold prices are expected to remain "elevated and volatile" due to geopolitical tensions, Titan said, but expressed optimism about the long-term growth prospects of the jewellery market on favourable demographics and its safe-haven appeal. Despite these challenges, the "outlook in India remains positive" due to favourable demographics and the continued relevance of jewellery as a store of value; however, "short-term demand fluctuations may persist", Titan said in its annual report. "Gold prices are expected to remain elevated and volatile, given ongoing geopolitical developments and global conflicts leading to macroeconomic uncertainties," said Titan, a JV between Tata and the Tamil Nadu government. The Tata group-managed firm also said these macroeconomic uncertainties arising from geopolitical developments could lead to shifts in demand patterns across customer segments. "In this environment, there could be shifts in demand segments and the Division will continue to prioritise mar

HCL Tech to Infosys, Tech Mahindra: IT stocks extend gains, Nifty IT up 3% today: Is worst over for the battered sector?

IT stocks gained on July 3, propelled by positive global tech trends and reduced fears of an interest rate hike. The Nifty IT index surged nearly 3%, recovering from recent declines, though it remains the worst-performing sector this year, down 30% in H1CY26.

HCL Tech shares zoom 6% after $1.14 billion AI deal with Fortune Global 50 firm

HCL Tech shares surged following a significant $1.14 billion deal with a European Fortune Global 50 firm to manage its digital workplace and networks. This new business, spanning July 2026 to December 2031, boosts HCL Tech's prospects. The company also recently invested in AI startup Sarvam AI. Despite a slight miss on FY26 revenue guidance, Q4 saw a 4.2% net profit increase.

HCL Tech Share Price Live Updates: HCL Tech shares zoom 6% after $1.14 billion AI deal with Fortune Global 50 firm

Medical device maker Zimmer Biomet to hire 500 employees in 3 years for tech centre in India

Medical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its new Bengaluru technology hub. Focusing on AI, software engineering, and R&D, the company aims to drive innovation in orthopedic implants and surgical devices. This move underscores India's growing importance as a global capability center for healthcare firms.

Tata Technologies shares jump 9% after expanding strategic partnership with Tenneco

Tata Technologies shares rose 9% to ₹729.20 after announcing an expanded partnership with Tenneco LLC. The agreement involves over $100 million investment to enhance engineering innovation and digital transformation, leveraging India's engineering talent for global automotive needs.

Tata Technologies expands partnership with Tenneco in $100 million deal

Tata Technologies and Tenneco LLC have inked a significant five-year deal exceeding $100 million to boost engineering and digital transformation. This expanded partnership, leveraging India's engineering talent, aims to accelerate product development and deploy AI-driven solutions across Tenneco's global automotive operations. The collaboration will enhance Tenneco's responsiveness to market shifts and strengthen its engineering prowess.

INR slumps back beyond Rs 95 per dollar mark as dollar stays firm; positive local equities cap downside

The Indian rupee depreciated 67 paise to close near a three-week low of 95.23 (provisional) against the US dollar on Wednesday, as a strengthening dollar index weighed on emerging market currencies. The USD/INR pair witnessed significant pressure due to the strengthening of the American currency in the overseas market, persistent capital outflows, and broader Asian currency weakness. Moreover, market sentiment turned highly cautious, following the breach of the psychological level of 95.00. Local equities also rebounded driven by positive global cues, a drop in crude oil prices, and easing geopolitical tensions. The NSE Nifty 50 gained 140.10 points (0.59%) to close at 24,005.85, while the BSE Sensex climbed 443.97 points (0.58%) to settle at 76,922.64.

Nifty reclaims 24,000 as auto, FMCG stocks drive market rebound

Benchmark indices snapped a two-day losing streak on Wednesday, supported by broad-based buying in auto, FMCG and financial stocks, while IT shares remained under pressure following KPIT Technologies' weak Q1 FY27 outlook. The Nifty reclaimed the 24,000 mark, while broader markets also ended higher. Positive global cues and value buying in beaten-down large-cap stocks lifted overall market sentiment.

mRNA vaccines protect against severe infectious diseases, review confirms

Billions of mRNA vaccine doses administered globally confirm their safety and effectiveness against infectious diseases, including severe COVID-19, across all age groups and health conditions. Researchers emphasize that serious side effects are rare, with benefits far outweighing risks. This technology, now proven, holds immense promise for future vaccines and personalized treatments, though equitable global access remains crucial.